位置:首页 > 蛋白库 > NR3AA_DANRE
NR3AA_DANRE
ID   NR3AA_DANRE             Reviewed;        1697 AA.
AC   A1XQX8; A1XQX9;
DT   21-SEP-2011, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 1.
DT   03-AUG-2022, entry version 86.
DE   RecName: Full=Neurexin-3a;
DE   AltName: Full=Neurexin IIIa-alpha;
DE   AltName: Full=Neurexin-3a-alpha;
DE   Flags: Precursor;
GN   Name=nrxn3a;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Danionidae; Danioninae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1A AND 2A), DEVELOPMENTAL STAGE, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=17041151; DOI=10.1093/molbev/msl147;
RA   Rissone A., Monopoli M., Beltrame M., Bussolino F., Cotelli F., Arese M.;
RT   "Comparative genome analysis of the neurexin gene family in Danio rerio:
RT   insights into their functions and evolution.";
RL   Mol. Biol. Evol. 24:236-252(2007).
CC   -!- FUNCTION: Neuronal cell surface protein that may be involved in cell
CC       recognition and cell adhesion.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=3;
CC         Comment=A number of isoforms, alpha-type and beta-type are produced
CC         by alternative promoter usage. Beta-type isoforms differ from
CC         alpha-type isoforms in their N-terminus.;
CC       Name=1a;
CC         IsoId=A1XQX8-1; Sequence=Displayed;
CC       Name=2a; Synonyms=Soluble form;
CC         IsoId=A1XQX8-2; Sequence=VSP_041706, VSP_041707;
CC       Name=1b;
CC         IsoId=A1XQY0-1; Sequence=External;
CC   -!- DEVELOPMENTAL STAGE: After the very early developmental stages, the
CC       expression levels decrease and remain relatively constant until around
CC       24 h, with the onset of an increase of expression that continues till
CC       the larval stages. {ECO:0000269|PubMed:17041151}.
CC   -!- MISCELLANEOUS: [Isoform 2a]: Produced by alternative splicing.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the neurexin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ641432; ABG25169.1; -; mRNA.
DR   EMBL; DQ641433; ABG25170.1; -; mRNA.
DR   RefSeq; NP_001073478.1; NM_001080009.1. [A1XQX8-2]
DR   AlphaFoldDB; A1XQX8; -.
DR   SMR; A1XQX8; -.
DR   STRING; 7955.ENSDARP00000082612; -.
DR   PaxDb; A1XQX8; -.
DR   PeptideAtlas; A1XQX8; -.
DR   PRIDE; A1XQX8; -.
DR   GeneID; 563598; -.
DR   KEGG; dre:563598; -.
DR   CTD; 563598; -.
DR   ZFIN; ZDB-GENE-070206-9; nrxn3a.
DR   eggNOG; KOG3514; Eukaryota.
DR   InParanoid; A1XQX8; -.
DR   OrthoDB; 35129at2759; -.
DR   PhylomeDB; A1XQX8; -.
DR   Reactome; R-DRE-6794361; Neurexins and neuroligins.
DR   Proteomes; UP000000437; Genome assembly.
DR   Proteomes; UP000814640; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   CDD; cd00110; LamG; 6.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR003585; Neurexin-like.
DR   InterPro; IPR027789; Syndecan/Neurexin_dom.
DR   Pfam; PF02210; Laminin_G_2; 6.
DR   Pfam; PF01034; Syndecan; 1.
DR   SMART; SM00294; 4.1m; 1.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00282; LamG; 6.
DR   SUPFAM; SSF49899; SSF49899; 6.
DR   PROSITE; PS50026; EGF_3; 3.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 6.
PE   2: Evidence at transcript level;
KW   Alternative promoter usage; Alternative splicing; Angiogenesis; Calcium;
KW   Cell adhesion; Disulfide bond; EGF-like domain; Membrane; Metal-binding;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..1697
FT                   /note="Neurexin-3a"
FT                   /id="PRO_0000412549"
FT   TOPO_DOM        24..1622
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1623..1643
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1644..1697
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          24..198
FT                   /note="Laminin G-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          194..231
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          258..455
FT                   /note="Laminin G-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          462..654
FT                   /note="Laminin G-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          658..695
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          700..872
FT                   /note="Laminin G-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          886..1061
FT                   /note="Laminin G-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          1073..1110
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1114..1314
FT                   /note="Laminin G-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   REGION          1345..1366
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1442..1479
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1520..1557
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1665..1697
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1447..1462
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1524..1550
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1665..1679
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1680..1697
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         304
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         321
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         389
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   DISULFID        198..209
FT                   /evidence="ECO:0000250"
FT   DISULFID        203..218
FT                   /evidence="ECO:0000250"
FT   DISULFID        220..230
FT                   /evidence="ECO:0000250"
FT   DISULFID        419..455
FT                   /evidence="ECO:0000250"
FT   DISULFID        625..654
FT                   /evidence="ECO:0000250"
FT   DISULFID        662..673
FT                   /evidence="ECO:0000250"
FT   DISULFID        667..682
FT                   /evidence="ECO:0000250"
FT   DISULFID        684..694
FT                   /evidence="ECO:0000250"
FT   DISULFID        1033..1061
FT                   /evidence="ECO:0000250"
FT   DISULFID        1077..1088
FT                   /evidence="ECO:0000250"
FT   DISULFID        1082..1097
FT                   /evidence="ECO:0000250"
FT   DISULFID        1099..1109
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1390..1425
FT                   /note="GGELVFPVIVKDPLELPSVATRTPSIPFPPTLTIIE -> AKNVNAARPLRT
FT                   AYTWTWQLTYTITPIIVISYVVCS (in isoform 2a)"
FT                   /evidence="ECO:0000303|PubMed:17041151"
FT                   /id="VSP_041706"
FT   VAR_SEQ         1426..1697
FT                   /note="Missing (in isoform 2a)"
FT                   /evidence="ECO:0000303|PubMed:17041151"
FT                   /id="VSP_041707"
SQ   SEQUENCE   1697 AA;  187194 MW;  FA961C8C4306CB26 CRC64;
     MNFFRFPVQL QLLISTVLGP CLGLEFTGLQ GQWARYLRWD ASTRSDLSFQ FKTDVSTALI
     LYFDDGGFCD FLQLMVVEGK LQLQFSIDCA ETTVVSDKRV NDSSWHSATL SRYNLRTVLG
     LDGVSKWAEV RPLRQYMKIV SDLFLGGVPQ DIRISVLTLP TVKDLPPFKG IIRELKYNSK
     EPILLSSQRV RMDIEGICME NPCENGGTCS VVDGEPLCDC SKTEYVGRFC NEEANNIPGF
     AHMMMADQAK GKAREENVAT FRGSEFFCYD LSQNPIQSSS DEITLSFKTW QRNGLILHTG
     KSADYVNLAL KDGAVSLVIN LGSGAFEAIV EPVNGKFNDN SWHDVKVTRN LRQHSGIGHA
     MVNKLHCLVT ISVDGILTTT GYTQEDYTML GSDDFFYVGG SPSTADLPGS PVSNNFMGCL
     KEVVYKNNDI RLELSRLARI VDPKMKIQGD VVFKCENVAT LDPISFETPE AYISLPKWNT
     KRMGSISFDF RTTEPNGLIL FTHGKPQERK DARSQKNTKV DFFAVELLDG SLYLLLDMGS
     GTIKVKATQN KVNDGAWYHV DIQRDGRSGT ISVNSRRTPF TASGENEILD LEGDMYLGGL
     PDSRGSLILP TELWTAMLNY GYVGCIRDLF IDGRSKDIRQ IAEAQNGAGI KPSCNKMSGK
     QCDSYPCKNK GLCKEGWNRF ICDCTGTGYW SRTCEREASI LSYDGSMYMK VVMPTVMHTE
     AEDVSLRFMS QRAYGLLMAT TSRDSADTLR LELDGSRVKL TVNLDCIRIN CNSSKGPETL
     YAGQKLNDNE WHTVRVIRRG KSYKLTVDDD VAEGQMVGDH TRLEFHNIET GVMTERRFVS
     MIPSSFIGHL QSLKFNGLLY IDLCKNGDID FCELNARFGM RSIIADPVTF KSKNSYLSLA
     TLQAYTSMHL FFQFKTTSAD GFILFNSGDG SDFIAVELVK GYIHYVFNLG NGPNVIKGNS
     ERALHDNQWH NVVITRDNSN VHTLKVDAKA VSQVVNGAKN LDLKGDLFIA GLGPNMYNNL
     PKLVASREGF KGCLASVDLN GRLPDLINDA LFRSGQIERG CEVGFTKADL KGPSTTCQED
     SCANMGICIQ QWENYTCDCS MTSYTGTHCN DPGTTYIFGK GGGLISFNWP ANERPSTRTD
     RLTVGFSTSL KDGILIRIDS APGLGDYLML HIEQGKIGVT FNIGTADITV QESSTAVNDG
     KYHVVRFTRN GGNATLQVDN WAINEHFPSG NSDNERIQMA NKKIPFKYAR PVEEWLQEKG
     RQLTIFNTQA TITIGGSDRK RPFQGQLSGL YYNGLKVLNM AAQGNPNIKI NGSVRLVGEV
     PAAGSARTTA LPPEMSTAFI ETTTTMSTTT TRKHRTPPTI QTTDDMVSSA ECSSDDEDFA
     ECEGHAGGLG GELVFPVIVK DPLELPSVAT RTPSIPFPPT LTIIETTKES LSMATEAGVP
     CLSDGGSDDC GDDDDDDDDD GLMISGYGSG EAYDSNLPPT DDEDFYTTFS LVTDKTLSSS
     TFEGGYKAHA PKWGSKDFRP NKVFDSGRTT TASFSPKLSR STTTSTPPKL PAGKMNHREL
     KPQPDIVLLP LPTSYEVDNT KMKSPLITSP MFRNVPTAIP TEPGIRRVPG ASEVVRESSS
     TTGMVVGIVA AAALCILILL YAMYKYRNRD EGSYQVDETR NYITNSAQSN GAVMKDKQQS
     TKSGNKKQKN KDKEYYV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024